Prism Medico & Pharmacy Analysis

dividend

Pros

Cons

• Unable to evaluate Prism Medico and Pharmacy's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
• Unable to evaluate Prism Medico and Pharmacy's dividend against the top 25% market benchmark as the company has not reported any payouts.

health

Pros

• Prism Medico and Pharmacy is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
• Prism Medico and Pharmacy has been profitable on average in the past, therefore cash runway is not a concern.
• Prism Medico and Pharmacy has been profitable on average in the past, therefore cash runway is not a concern.
• Prism Medico and Pharmacy has no debt, it does not need to be covered by operating cash flow.
• Prism Medico and Pharmacy has no debt, it does not need to be covered by short term assets.
• Prism Medico and Pharmacy's cash and other short term assets cover its long term commitments.
• Prism Medico and Pharmacy had no debt 5 years ago.
• Prism Medico and Pharmacy has no debt, therefore coverage of interest payments is not a concern.
• Prism Medico and Pharmacy has no debt.

Cons

• High level of physical assets or inventory.

management

Pros

Cons

• The average tenure for the Prism Medico and Pharmacy board of directors is less than 3 years, this suggests a new board.

misc

Pros

Cons

• Prism Medico and Pharmacy is not covered by any analysts.
• Prism Medico and Pharmacy has significant price volatility in the past 3 months.

past

Pros

Cons

• Unable to compare Prism Medico and Pharmacy's 1-year earnings growth to the 5-year average as it is not currently profitable.
• Prism Medico and Pharmacy does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
• It is difficult to establish if Prism Medico and Pharmacy has efficiently used its assets last year compared to the IN Food industry average (Return on Assets) as it is loss-making.
• It is difficult to establish if Prism Medico and Pharmacy improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
• It is difficult to establish if Prism Medico and Pharmacy has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
• Unable to compare Prism Medico and Pharmacy's 1-year growth to the IN Food industry average as it is not currently profitable.

value

Pros

• Prism Medico and Pharmacy is good value based on assets compared to the IN Food industry average.
• BSE:512217 is up 30.4% outperforming the Food industry which returned 5% over the past month.
• BSE:512217 is up 30.4% outperforming the market in India which returned 8% over the past month.

Cons

• Prism Medico and Pharmacy is loss making, we can't compare its value to the IN Food industry average.
• Prism Medico and Pharmacy is loss making, we can't compare the value of its earnings to the India market.
• 512217 underperformed the Food industry which returned 18.8% over the past year.
• 512217 underperformed the Market in India which returned -14.5% over the past year.